ELIZABETH TYSON: Open Payments
NPI 1750951323 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,574 in 103 payments from 27 companies in 2025. Trend: 2023 $240 · 2024 $125 · 2025 $2,574
Food & beverage: $2,574
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $271 |
| UCB, Inc. | 8 | $268 |
| Alexion Pharmaceuticals, Inc. | 6 | $248 |
| Biogen, Inc. | 10 | $223 |
| Lundbeck LLC | 6 | $157 |
| ARGENX US, INC. | 5 | $156 |
| TG Therapeutics, Inc. | 5 | $155 |
| PFIZER INC. | 8 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $123 |
| Neurelis, Inc. | 4 | $99 |
Products named: ULTOMIRIS, LEQEMBI, QULIPTA, VYVGART HYTRULO, BRIUMVI, NURTEC ODT, HYQVIA, REXULTI.
Industry payments across GA — which companies pay providers there.
